GlassScriptPhysician profile
Bruce A Seideman
NPI 1427005495
$1,735.14
in general payments reported to CMS, 2019-2025
14 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $11.59 · 2021: $169 · 2022: $376 · 2023: $180 · 2024: $276 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $534.29 | 2021-2025 | Rosa, Persona |
| Hitachi Healthcare Americas Corp. | $316.24 | 2019 | |
| Bioventus LLC | $209.49 | 2022-2023 | Durolane |
| Inspire Medical Systems, INC. | $135.97 | 2024 | Inspire |
| Cumberland Pharmaceuticals, INC. | $135.54 | 2019-2025 | Caldolor |
| Djo, LLC | $114.94 | 2024 | Cmf |
| Endo Pharmaceuticals INC. | $70.17 | 2022-2024 | Xiaflex |
| Medtronic, INC. | $58.33 | 2023 | V-Loc 180 |
| Orthofix Medical, INC. | $48.98 | 2019 | |
| Merck Sharp & Dohme LLC | $42.79 | 2022-2023 | Bridion |
| Si-Bone, INC. | $21.03 | 2019 | |
| Molnlycke Health Care US, LLC | $19.15 | 2023 | Avance, Mepilex Border Post-Op Ag |
| Ferring Pharmaceuticals INC. | $16.63 | 2022 | |
| Nevro Corp. | $11.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Seideman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.